Stocktoria

Ping An Biomedical Co., Ltd. PASW

Ping An Biomedical Co., Ltd. financials (annual)

Revenue
$87.6M $4.8M 20242025
Net income
-$1.3M -$1.8M 20242025
Free cash flow
20242025

Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024
Revenue$4.8M$87.6M
Gross profit$133,376$5.4M
Operating income-$2.1M-$2,039
Income tax$260,653-$601,456
Net income-$1.8M-$1.3M
EPS (diluted)$-0.10$-0.07
Operating cash flow-$902,902$14.6M
Cash & equivalents$164,697$130,923
Inventory$62,074$127,296
Total assets$9.6M$56.8M
Total liabilities$3.3M$64.0M
Shareholders' equity$6.4M-$7.2M

Growth · year-over-year · Revenue CAGR -94.5%

MetricFY2025FY2024
Revenue growth-94.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.